മോഡേണ കോവിഡ് ‑ 19 വാക്സിൻ

മോഡേണ കോവിഡ് ‑ 19 വാക്സിൻ
	Vials of the Moderna COVID-19 vaccine
Vaccine description
Target	SARS-CoV-2
Vaccine type	mRNA
Clinical data
Pronunciation	/məˈdɜːrnə/ mə-DUR-nə
Trade names	Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna
Other names	mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna
AHFS/Drugs.com
MedlinePlus	a621002
License data	US DailyMed: Moderna_COVID-19_Vaccine;
Routes of; administration	Intramuscular
ATC code	None;
Legal status
Legal status	CA: Schedule D; Authorized by interim order; UK: Marketing authorization granted; US: Standing Order; Unapproved (Emergency Use Authorization); EU: Conditional marketing authorization granted;
Identifiers
DrugBank	DB15654;
UNII	EPK39PL4R4;

[[Category:Infobox drug articles with contradicting parameter input |]]

മോഡേണ, യുണൈറ്റഡ് സ്റ്റേറ്റ്സ് നാഷണൽ ഇൻസ്റ്റിറ്റ്യൂട്ട് ഓഫ് അലർജി ആൻഡ് ഇൻഫെക്റ്റിയസ് ഡിസീസസ് (NIAID), ബയോമെഡിക്കൽ അഡ്വാൻസ്ഡ് റിസർച്ച് ആൻഡ് ഡവലപ്മെൻറ് അതോറിറ്റി (BARDA) എന്നിവ വികസിപ്പിച്ചെടുത്ത കോവിഡ് -19 വാക്സിനാണ് എം‌ആർ‌എൻ‌എ -1273 എന്ന രഹസ്യനാമമുള്ള മോഡേണ കോവിഡ് ‑ 19 വാക്സിൻ. കൊറോണ വൈറസ് രോഗം 2019 ന് കാരണമാകുന്ന SARS-CoV-2 വൈറസ് അണുബാധയിൽ നിന്ന് സംരക്ഷണം നൽകാൻ 18 വയസും അതിൽ കൂടുതലുമുള്ള ആളുകളിൽ ഇത് ഉപയോഗിക്കുന്നു. നാല് ആഴ്ച ഇടവേളയിൽ 0.5 മില്ലി വീതമുള്ള രണ്ട് ഡോസുകളായി ഇൻട്രാമസ്കുലർ കുത്തിവയ്പ്പ് നൽകുന്ന രീതിയിലാണ് ഇത് രൂപകൽപ്പന ചെയ്തിട്ടുള്ളത്.^[12]

അമേരിക്ക, യൂറോപ്യൻ യൂണിയൻ, യുണൈറ്റഡ് കിംഗ്ഡം, ഇസ്രായേൽ, സിംഗപ്പൂർ എന്നിവയുൾപ്പെടെ 45 രാജ്യങ്ങളിൽ മോഡേണ കോവിഡ് -19 വാക്സിൻ ചില തലങ്ങളിൽ ഉപയോഗിക്കാൻ അധികാരപ്പെടുത്തിയിട്ടുണ്ട്.^[13] 2021 മാർച്ച് 15 ന് മോഡേണയുടെ രണ്ടാമത്തെ കോവിഡ്‌-19 വാക്സിന്റെ ( 'mRNA-1283' ) ആദ്യ ക്ലിനിക്കൽ പരീക്ഷണങ്ങൾ ആരംഭിച്ചു.^[14]

അവലംബങ്ങൾ

↑ Moderna (23 October 2019). mRNA-3704 and Methylmalonic Acidemia (Video). YouTube. Retrieved 19 January 2021.
↑ "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada. 23 December 2020. Retrieved 23 December 2020.
↑ "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)". COVID-19 vaccines and treatments portal. 23 December 2020. Retrieved 23 December 2020.
↑ "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.
↑ "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.
↑ "Regulatory approval of COVID-19 Vaccine Moderna". gov.uk. 1 April 2021.
↑ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". Food and Drug Administration (Press release). Retrieved 18 December 2020.
↑ "Moderna COVID-19 Vaccine – cx-024414 injection, suspension". DailyMed. Retrieved 20 December 2020.
↑ Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). Food and Drug Administration (Report). 18 December 2020. Retrieved 20 December 2020. This article incorporates text from this source, which is in the public domain.
↑ "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC).
↑ "COVID-19 Vaccine Moderna EPAR". European Medicines Agency (EMA). Retrieved 20 January 2021.
↑ "Moderna COVID-19 Vaccine". Dosing & Administration. Infectious Diseases Society of America. 4 January 2021. Archived from the original on 2020-12-20. Retrieved 5 January 2021.
↑ "COVID-19 Vaccine Tracker: Moderna: mRNA-1273". McGill University. Archived from the original on 2021-12-13. Retrieved 2021-05-09.
↑ "First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna's Next Generation COVID-19 Vaccine" (Press release). Moderna. 15 March 2021 – via Business Wire.

[1] Moderna (23 October 2019). mRNA-3704 and Methylmalonic Acidemia (Video). YouTube. Retrieved 19 January 2021.

[CA_Moderna_decision-2] "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada. 23 December 2020. Retrieved 23 December 2020.

[CA_Moderna_product_description-3] "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)". COVID-19 vaccines and treatments portal. 23 December 2020. Retrieved 23 December 2020.

[gov.uk-4] "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.

[Conditions_of_Authorisation_for_COV-5] "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.

[UKapproval-6] "Regulatory approval of COVID-19 Vaccine Moderna". gov.uk. 1 April 2021.

[FDA_PR_20201218-7] "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". Food and Drug Administration (Press release). Retrieved 18 December 2020.

[Moderna_COVID-19_Vaccine_FDA_label-8] "Moderna COVID-19 Vaccine – cx-024414 injection, suspension". DailyMed. Retrieved 20 December 2020.

[Moderna_COVID-19_Vaccine_FDA_EUA-9] Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). Food and Drug Administration (Report). 18 December 2020. Retrieved 20 December 2020. This article incorporates text from this source, which is in the public domain.

[10] "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC).

[COVID-19_Vaccine_Moderna_EPAR-11] "COVID-19 Vaccine Moderna EPAR". European Medicines Agency (EMA). Retrieved 20 January 2021.

[IDSA-12] "Moderna COVID-19 Vaccine". Dosing & Administration. Infectious Diseases Society of America. 4 January 2021. Archived from the original on 2020-12-20. Retrieved 5 January 2021.

[13] "COVID-19 Vaccine Tracker: Moderna: mRNA-1273". McGill University. Archived from the original on 2021-12-13. Retrieved 2021-05-09.

[14] "First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna's Next Generation COVID-19 Vaccine" (Press release). Moderna. 15 March 2021 – via Business Wire.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]